Business Description
Singapore Institute Of Advanced Medicine Holdings Ltd
ISIN : SGXE79544776
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.56 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.89 | |||||
Beneish M-Score | -3.52 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | -74.7 | |||||
3-Year EPS without NRI Growth Rate | -72.3 | |||||
3-Year FCF Growth Rate | -26 | |||||
3-Year Book Growth Rate | 9.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 98.06 | |||||
9-Day RSI | 87.53 | |||||
14-Day RSI | 74.35 | |||||
6-1 Month Momentum % | -25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.37 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -80.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PS Ratio | 4 | |||||
PB Ratio | 1.02 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | -4.9 | |||||
EV-to-EBITDA | -9.45 | |||||
EV-to-Revenue | 7.61 | |||||
EV-to-FCF | -8.25 | |||||
Earnings Yield (Greenblatt) % | -20.42 | |||||
FCF Yield % | -16.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Singapore Institute Of Advanced Medicine Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil S$) | 16.646 | ||
EPS (TTM) (S$) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 74.35 | ||
14-Day ATR (S$) | 0.00136 | ||
20-Day SMA (S$) | 0.0687 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (S$) | 0.062 - 0.195 | ||
Shares Outstanding (Mil) | 1,048.1 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Singapore Institute Of Advanced Medicine Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Singapore Institute Of Advanced Medicine Holdings Ltd Stock Events
Event | Date | Price(S$) | ||
---|---|---|---|---|
No Event Data |
Singapore Institute Of Advanced Medicine Holdings Ltd Frequently Asked Questions
What is Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2)'s stock price today?
When is next earnings date of Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2)?
Does Singapore Institute Of Advanced Medicine Holdings Ltd(SGX:9G2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |